Form 4 Tracker
Kymera Therapeutics, Inc.
KYMR

24 insider filings · Latest: May 11, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Apr 9, 2026Apr 10 8:45 PMNoah GoodmanChief Business Officer
Sale
8,264$87.50$723.1K53,542.438(D)

View →

Apr 9, 2026Apr 9 8:28 PMNoah Goodman
Proposed Sale
11,611$87.35$1.0M

View →

Apr 1, 2026Apr 1 11:00 PMElena RidloffDirector
Sale
4,600$85.42$392.9K0(D)

View →

Apr 1, 2026Apr 1 11:00 PMJeremy G ChadwickChief Operating Officer
Sale
14,640$85.46$1.3M61,202(D)

View →

Mar 31, 2026Apr 1 11:00 PMJeremy G ChadwickChief Operating Officer
Sale
7,600$85.38$648.9K61,202(D)

View →

Mar 31, 2026Apr 1 11:00 PMElena RidloffDirector
Sale
7,400$85.37$631.7K0(D)

View →

Apr 1, 2026Apr 1 8:42 PMELENA RIDLOFF
Proposed Sale
4,600$83.29$383.1K

View →

Apr 1, 2026Apr 1 8:42 PMJEREMY CHADWICK
Proposed Sale
14,640$83.29$1.2M

View →

Mar 31, 2026Mar 31 8:21 PMJEREMY CHADWICK
Proposed Sale
7,600$79.48$604.0K

View →

Mar 31, 2026Mar 31 8:19 PMELENA RIDLOFF
Proposed Sale
7,400$79.48$588.2K

View →

Mar 25, 2026Mar 25 9:15 PMJeremy G ChadwickChief Operating Officer
Sale
24,727$80.26$2.0M61,202(D)

View →

Mar 23, 2026Mar 25 9:15 PMJeremy G ChadwickChief Operating Officer
Sale
91,250$77.41$7.1M61,202(D)

View →

Mar 23, 2026Mar 23 8:36 PMJEREMY CHADWICK
Proposed Sale
115,977$77.91$9.0M

View →

Mar 20, 2026Mar 20 10:30 PMPamela EspositoDirector
Sale
2,500$79.15$197.9K0(D)

View →

Mar 20, 2026Mar 20 8:35 PMPAMELA ESPOSITO
Proposed Sale
2,500$79.57$198.9K

View →

Mar 11, 2026Mar 11 10:51 PMJeremy G ChadwickChief Operating Officer
Sale
25,758$83.30$2.1M68,052(D)

View →

Mar 11, 2026Mar 11 8:40 PMJEREMY CHADWICK
Proposed Sale
25,758$84.58$2.2M

View →

Mar 4, 2026Mar 4 11:00 PMJeremy G ChadwickChief Operating Officer
Sale
3,919$85.30$334.3K73,810(D)

View →

Mar 2, 2026Mar 4 11:00 PMJeremy G ChadwickChief Operating Officer
Sale
2,039$88.93$181.3K77,729(D)

View →

Mar 4, 2026Mar 4 11:00 PMJared GollobChief Medical Officer
Sale
4,895$85.30$417.5K117,134(D)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Mar 2, 2026Mar 4 11:00 PMJared GollobChief Medical Officer
Grant/Award
35,300$90.1035,300(D)

View →

Mar 2, 2026Mar 4 11:00 PMBruce N. JacobsChief Financial Officer
Grant/Award
35,300$90.1035,300(D)

View →

Mar 2, 2026Mar 4 11:00 PMNello MainolfiDirector, Chief Executive Officer
Grant/Award
215,000$90.10215,000(D)

View →

Feb 25, 2026Feb 25 10:24 PMNello MainolfiDirector, Chief Executive Officer
Option Exercise
30,000$2.08245,559(D)

View →

Feb 20, 2026Feb 20 10:30 PMPamela EspositoDirector
Option Exercise
2,500$49.102,500(D)

View →

Jan 20, 2026Jan 20 11:30 PMPamela EspositoDirector
Option Exercise
5,500$49.105,000(D)

View →

Dec 31, 2025Dec 31 10:23 PMNello MainolfiDirector, Chief Executive Officer
Option Exercise
30,000$2.08275,559(D)

View →

← Previous

Page 2 of 2